Waterloo Institute for Nanotechnology
Mike & Ophelia Lazaridis Quantum-Nano Centre, QNC 3606
University of Waterloo
200 University Avenue West,
Waterloo, ON N2L 3G1
519-888-4567, ext. 38654
win-office@uwaterloo.ca
Research interests: optical properties of the eye; refractive properties of the crystalline confocal laser scanning; macroscopy
In 2004, Professor Melanie Campbell was awarded the Rank Prize, the world’s most prestigious award in prestigious in optoelectronics. Campbell cited her work as: an initial idea has been carried through to practical applications that have, or will, demonstrably benefit mankind.
Campbell is well known for her work on the gradient index optics of the crystalline lens. She has developed and patented improved scanning laser, adaptive optics and polarization methods for imaging the eye and biological tissues. She uses lasers to improve diagnosis and to study highly localized, light activated therapies for eye diseases.
Campbell earned a PhD in Applied Mathematics and Physiology from the Australian National University in 1982. Following a Commonwealth Scientific and Industrial Research Organisation (CSIRO) Fellowship at the Institute of Mathematics and Statistics in Canberra, Campbell returned to Canada in 1984 with an Natural Sciences and Engineering Research Council of Canada (NSERC) University Research Fellowship. Campbell is a Fellow of the Optical Society of America, a Fellow of the Institute of Physics (U.K.), and a Honourary Professional Certification (PPhys) and former President of the Canadian Association of Physicists. Campbell is involved in a diploma program in photonics for industry, undertakes collaborative research with industry and was co-founder of Biomedical Photometrics Inc.
Melanie Campbell is currently a Professor in the Department of Physics and is cross-appointed to the School of Optometry. In addition, Professor Campbell is a University Research Chair at the University of Waterloo. Professor Campbell’s nano bio projects include the development of light activated therapies for eye diseases; the restoration of crystalline lens elasticity with multiphoton treatments; studies of amyloid beta at the nanoscale in the eye and high resolution wavefront sensing and imaging with adaptive optics. She and collaborators are developing a precisely deformable ferrofluid mirror consisting of magnetic nanoparticles.
Professor Campbell undertakes experimental and theoretical research in the optical quality of the eye, ophthalmic imaging and biophotonics, including at the nanoscale. She also studies ocular development, eye disease and linear and nonlinear optics of the eye. She has collaborated in the first real-time images of cones at the rear of the eye, the first adaptive optics confocal imaging paper and patents in polarization imaging which will improve imaging in ophthalmoscopy and microscopy. Professor Campbell recently discovered putative optical signals to eye growth which appear to follow a circadian rhythm. She is interested in improved optical imaging for diagnosis and novel therapies for eye disease.
Recent publications include:
Please see Melanie Campbell's Google Scholar profile for a current list of her peer-reviewed articles.
Office: PHY 353
Phone: 519-888-4567, ext.36273
Email: melanie.campbell@uwaterloo.ca
Website: Melanie Campbell
Waterloo Institute for Nanotechnology
Mike & Ophelia Lazaridis Quantum-Nano Centre, QNC 3606
University of Waterloo
200 University Avenue West,
Waterloo, ON N2L 3G1
519-888-4567, ext. 38654
win-office@uwaterloo.ca
The University of Waterloo acknowledges that much of our work takes place on the traditional territory of the Neutral, Anishinaabeg and Haudenosaunee peoples. Our main campus is situated on the Haldimand Tract, the land granted to the Six Nations that includes six miles on each side of the Grand River. Our active work toward reconciliation takes place across our campuses through research, learning, teaching, and community building, and is co-ordinated within our Office of Indigenous Relations.